
Revolutionizing Cancer Treatment: The Incredible Power of Engeneics’ Nanocell Drug Conjugate for Pancreatic Cancer Patients
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer SYDNEY and NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — EnGeneIC, a pioneer in personalised cancer therapeutics, announces the publication of its clinical trial results in peer reviewed prestigious journal “Clinical Cancer Research”, published by the American Association for Cancer Research….